In vitro endosome-lysosome transfer of dephosphorylated EGF receptor and Shc in rat liver  by Authier, François & Chauvet, Geneviève
In vitro endosome-lysosome transfer of dephosphorylated EGF receptor
and Shc in rat liver
Franc°ois Authiera;*, Genevie've Chauvetb
aInstitut National de la Sante¤ et de la Recherche Me¤dicale U510, Faculte¤ de Pharmacie Paris XI, 5 rue Jean-Baptiste Cle¤ment,
92296 Cha“tenay-Malabry, France
bInstitut National de la Sante¤ et de la Recherche Me¤dicale U30, Ho“pital Necker Enfants-Malades, 75015 Paris, France
Received 2 August 1999; received in revised form 12 October 1999
Abstract We have studied the endosome-lysosome transfer of
internalized epidermal growth factor receptor (EGFR) com-
plexes in a cell-free system from rat liver. Analytical subfraction-
ation of a postmitochondrial supernatant fraction showed that a
pulse of internalized [125I]EGF was largely associated with a light
endosomal fraction devoid of lysosomal markers. After an
additional 30 min incubation in vitro in the presence of an
ATP-regenerating system, the amount of [125I]EGF in this
compartment decreased by 39%, with an increase in [125I]EGF in
lysosomes. No transfer of [125I]EGF to the cytosol was detected.
To assess the fate of the internalized EGFR protein over the time
course of the endo-lysosomal transfer of the ligand, the effect of a
saturating dose of native EGF on subsequent lysosomal targeting
of the EGFR was evaluated by immunoblotting. A massive
translocation of the EGFR to the endosomal compartment was
observed in response to ligand injection coincident with its
tyrosine phosphorylation and receptor recruitment of the
tyrosine-phosphorylated adaptor protein Shc. During cell-free
endosome-lysosome fusion, a time-dependent increase in the
content of the EGFR and the two 55- and 46-kDa Shc isoforms
was observed in lysosomal fractions with a time course super-
imposable with the lysosomal transfer of the ligand; no transfer
of the 66-kDa Shc isoform was detected. The relationship
between EGFR tyrosine kinase activity and EGFR sorting in
endosomes investigated by immunoblot studies with anti-phos-
photyrosine antibodies revealed that endosomal dephosphoryla-
tion of EGFR and Shc preceded lysosomal transfer. These results
support the view that a lysosomal targeting machinery distinct
from the endosomal receptor kinase activity, such as the
recruitment of the signaling molecule Shc, may regulate this
sorting event in the endosome.
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1. Introduction
In mammals, the highest concentration of the epidermal
growth factor receptor (EGFR) is found in liver parenchyma
[1]. The hepatic EGFR is believed to be involved in liver
regeneration via mitogenic signaling pathways [2]. Ligand
mediated activation of the EGFR leads to a number of sub-
cellular events including the recruitment and tyrosine phos-
phorylation of Shc and the recruitment of Grb2 followed by
the activation of p21ras and downstream pathways [3]. Follow-
ing ligand binding and the initiation of signal transduction
pathways, the EGFR is rapidly tra⁄cked to coated pits, in-
ternalized and ultimately degraded when endosomes fuse with
lysosomes [4,5].
While receptor tyrosine kinases (RTKs) such as those for
EGF and PDGF are targeted largely to lysosomes for degra-
dation others such as the RTKs for insulin and IGF-I are
recycled largely to the plasma membrane [6]. Hence, a machi-
nery must exist in the endosome to sort di¡erent receptors
into distinct vesicle populations. Data on the compartmental-
ization of the signaling responses of the EGFR in liver paren-
chyma support the view that the RTK activity is important
for ligand-induced sorting of this receptor to the pathway for
lysosomal degradation [7,8]. Thus, the EGFR is maximally
tyrosine-phosphorylated following internalization into endo-
somes as a consequence of a partial dissociation and degra-
dation of internalized EGF within endocytic vesicles [4,5,9].
We have recently demonstrated that the cysteine protease
cathepsin B down-regulates internalized EGF-EGFR com-
plexes within endosomes by inducing proteolytic cleavages
that yield C-terminal truncated forms of EGF [5]. EGFR
recruitment and tyrosine phosphorylation of endosomal sub-
strates may also regulate these sorting events. The complex of
tyrosine-phosphorylated Shc and Grb2 represents a relevant
candidate at this locus [7,10].
We have recently developed a method for assaying endo-
some-lysosome transfer of internalized ligand-receptor com-
plexes in hepatic tissue [11]. We have shown that in a liver
cell-free system containing in vivo endocytosed insulin, gluca-
gon and GalBSA, these ligands are transferred in vitro from
endosomes to lysosomes [11]. A low lysosomal transfer of the
K and L subunits of the insulin receptor also occurred during
endosome-lysosome interaction [11]. In the present work, we
used the in situ liver model system for endosome-lysosome
transfer to study (a) the endosomal fate of the internalized
EGF-EGFR complex; (b) the phosphorylation state of the
internalized EGFR during the fusion process; and (c) the
fate of EGFR-associated Shc, a major physiological substrate
for the EGFR tyrosine kinase.
2. Materials and methods
2.1. Peptides, ligand radioiodination, antibodies, protein determination,
enzyme assays and materials
Mouse EGF (receptor grade) was purchased from Collaborative
Biomedical. [125I]EGF (400^500 Ci/mmol) was prepared using chlor-
amine T and puri¢ed by gel ¢ltration on Sephadex G-50. Monoclonal
horseradish peroxidase (HRP)-conjugated antibody raised to phos-
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photyrosine was purchased from Amersham. Polyclonal antibody
raised to the SH2 domain (residues 366^473) of Shc and polyclonal
antibody to a synthetic peptide (residues 1164^1176) of the EGFR
used for immunoblotting were obtained from Dr. J.J.M. Bergeron
(McGill University, Montre¤al, Que., Canada) [7]. Rabbit anti-rat pro-
cathepsin B and rabbit anti-mouse cathepsin D were obtained from
Dr. John S. Mort (Shriners Hospital for Crippled Children, Montre¤al,
Que., Canada) [12]. HRP-conjugated goat anti-rabbit IgG was from
Bio-Rad. The protein content of isolated fractions was determined by
the method of Lowry et al. [13]. Galactosyltransferase was assayed as
described by Beaufay et al. [14]. Acid phosphatase was assayed as
described by Trouet [15]. 5P-Nucleotidase was assayed as described
by Heppel and Hillmoe [16]. Enhanced chemiluminescence (ECL) de-
tection kit was from Amersham. Polyacrylamide gel electrophoresis
(PAGE) reagents were from Bio-Rad. All other chemicals were ob-
tained from commercial sources and were of reagent grade.
2.2. Animals and injections
Male Sprague-Dawley rats, body weight 180^200 g, were obtained
from Charles River France (St. Aubin Les Elbeufs, France) and were
fasted for 18 h prior to killing. Native EGF (5 Wg/100 g body weight)
or [125I]EGF (20U106 cpm) were diluted in 0.3 ml of 0.15 M NaCl
and injected within 5 s into the penis vein under light ether anaesthe-
sia.
2.3. Isolation of subcellular fractions from rat liver and transfer
reaction
Subcellular fractionation was performed using established proce-
dures [17^19]. Animals were killed 10 min after injection of the ap-
propriate ligand and livers rapidly removed and minced in either iso-
tonic ice-cold homogenization bu¡er containing 0.25 M sucrose, 10
mM TES pH 7.4 and 7 mM MgCl2. Intact cells, nuclei and mitochon-
dria were removed from the homogenate by centrifugation at
33 000Ug for 1 min. The cell-free transfer reaction was carried out
as described previously by Chauvet et al. [11]. The postmitochondrial
supernatant (referred to as LPS fraction) was incubated at 4‡C or
37‡C, and, where indicated, in the presence of 5 mM ATP, 1 mg/ml
creatine kinase and 20 mM phosphocreatine. After cooling to 4‡C,
incubation mixtures were layered onto 10 ml linear gradients prepared
with 35% (mass/vol.) Nycodenz and 0.25 M sucrose containing 10 mM
TES pH 7.4 and 2 mM EDTA (density range, 1.06^1.16 g/ml). Gra-
dients were centrifuged at 200 000Ug for 60 min in a Beckman SW 41
rotor, following which 0.5 ml fractions were collected, densities deter-
mined and enzyme activity, radioactivity and immunoblot analyses
carried out. In some experiments the integrity of radiolabelled EGF
was assessed by precipitation with trichloroacetic acid (TCA)
[11,12,17^19].
2.4. Immunoblot studies
Electrophoresed samples were transferred to nitrocellulose blots
(0.45 Wm) for 60 min at 380 mAî in transfer bu¡er containing
25 mM Tris-base and 192 mM glycine. The blots were incubated
for 3 h with 5% skim milk or 2% bovine serum albumin (for phos-
photyrosine immunoblots) in 10 mM Tris-HCl pH 7.5, 300 mM NaCl
and 0.05% Tween-20. The blots were then incubated with primary
antibody (a⁄nity-puri¢ed polyclonal antibodies to Shc diluted
1:5000, EGFR diluted 1:5000, monoclonal anti-phosphotyrosine di-
luted 1:2500, polyclonal anti-procathepsin B diluted 1:200 and poly-
clonal anti-cathepsin D diluted 1:200) in the above bu¡er for 16 h at
4‡C. After incubation, the blots were washed three times with 0.5%
skim milk or 0.2% bovine serum albumin (for phosphotyrosine im-
munoblots) in 10 mM Tris-HCl pH 7.5, 300 mM NaCl and 0.05%
Tween-20 over a period of 1 h at room temperature. The bound
immunoglobulin was detected using HRP-conjugated goat anti-rabbit
IgG. Bands were detected using ECL and quanti¢ed by densitometric
scanning of the X-ray ¢lm of corresponding immunoblots.
3. Results
We have previously reported the steady-state distribution of
cathepsins in liver parenchyma detected with sensitive and
speci¢c antibodies [12]. Immunoblotting procedures per-
formed on highly enriched hepatic subfractions have indicated
that procathepsin B is membrane-bound in hepatic endosomes
whereas mature cathepsin D is mainly recovered in lysosomes.
We therefore used the well-characterized anti-cathepsin anti-
bodies to assess the distribution of endosomes and lysosomes
throughout the hepatic LPS fraction which was subfrac-
tionated on a linear Nycodenz gradient (Fig. 1C). Moreover,
other classical marker enzymes have been also assessed (Fig.
1A and B). Immediate analysis of LPS fraction on Nycodenz
gradients showed that the Golgi marker galactosyltransferase
and the endosomal procathepsin B enzyme were found in low
density fractions between 1.075^1.105 g/ml whereas the lyso-
somal markers acid phosphatase and cathepsin D were found
in high density fractions between 1.11^1.14 g/ml (Fig. 1A and
C). 5P-Nucleotidase, a plasma membrane marker, migrated as
a slightly denser peak (peak densityW1.105 g/ml) than the
Golgi marker galactosyltransferase (Fig. 1A). The distribution
of marker enzymes was almost unchanged when the LPS frac-
tion was incubated at 37‡C for 30 min in the presence of ATP
and an ATP-regenerating system (Fig. 1B). Thus, components
appearing at densities 1.075^1.105 and 1.11^1.14 g/ml were
scored, respectively, as truly endosomal and lysosomal.
Next, we examined the subcellular distribution of internal-
ized [125I]EGF associated with the LPS fraction over time
(Fig. 2A). Rats were administered an intravenous injection
of [125I]EGF and killed 10 min after injection, when most of
the ligand would be located in the endosomes [4,5,20]. Ana-
lytical subfractionation on Nycodenz gradients of the postmi-
tochondrial supernatants prepared from these livers showed
that the radioactivity appeared in a single broad peak of den-
sityW1.075^1.105 g/ml (Fig. 2A) clearly distinguished from
the peak of activity of the lysosomal enzyme markers acid
phosphatase and cathepsin D (see Fig. 1). Analysis of the
LPS fraction after a 30 min incubation at 37‡C in the presence
of ATP and an ATP-regenerating system showed that 24% of
the radioactivity had moved to a peak density 1.11^1.14 co-
inciding with the peak for the lysosomal enzyme markers (see
Fig. 1). Omission of ATP and an ATP-regenerating system
prevented any increase in radiolabel in the lysosomal position
after 30 min at 37‡C (Fig. 2A).
To evaluate the contribution of endosomal and lysosomal
components to [125I]EGF degradation, the integrity of the
ligand was assessed by precipitation with TCA (Fig. 2B).
With the LPS fraction kept at 4‡C, more radioactivity was
present in the TCA-soluble form in high density lysosomal
components (W40%) than in low density endocytic structures
(W33%). Incubation at 37‡C produced a rapid increase in
acid-soluble radioactivity recovered at the top of the gradient
suggesting that only small size breakdown products di¡used
out of the membrane endo-lysosomal compartment.
The time course of transfer of the EGFR from the endo-
somal to the lysosomal position was next examined by density
gradient analysis of the LPS fractions prepared from control
and EGF-injected rats (Fig. 2C). With control LPS fractions
prepared from non-injected rats, most of the EGFR was
found in the middle of the gradient between densities 1.080^
1.115 g/ml which coincided with 5P-nucleotidase, the plasma
membrane marker (see Fig. 1A and B). With LPS fractions
prepared from native EGF-treated rats and incubated at 4‡C,
most of the EGFR appeared in the endosomal region of the
gradient (1.075^1.100 g/ml). When the LPS fraction was in-
cubated at 37‡C for 15 min, the EGFR found in the endo-
somal region of the Nycodenz gradient was markedly reduced
as would be expected if some EGFR was being degraded
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enzymatically at this subcellular site [5,21]. After a 30 min
incubation at 37‡C, the EGFR distributed into two peaks.
The majority of the EGFR (81%) appeared in the endosomal
peak whereas a small fraction appeared in a dense peak
(1.127^1.132 g/ml) consistent with lysosomal compartmenta-
tion. No detectable amounts of EGFR movement occurred in
the absence of ATP and an ATP-regenerating system.
The EGFR phosphorylation state was next assessed by im-
munoblotting with monoclonal anti-phosphotyrosine antibod-
ies (Fig. 3). A strong phosphotyrosine content of the endo-
somal EGFR was observed when the LPS fraction was
incubated at 4‡C, as well as the presence of the tyrosine-phos-
phorylated 55-kDa form of Shc (Fig. 3A). Fig. 3B depicts the
decline in phosphotyrosine content of the EGFR and 55-kDa
Shc isoform after a 10 min incubation of the LPS fraction at
37‡C. In each case, there was a major loss of phosphotyrosine
content, with an immunoreactivity barely perceptible with the
endosomal EGFR. We conclude that a rapid EGFR phospho-
tyrosine dephosphorylation reaction was occurring in endo-
somes before the endo-lysosomal transfer event.
To evaluate the relationship between compartmentalization
and signaling, we isolated Nycodenz subfractions and eval-
uated them for the presence of the EGF-associated signaling
molecule Shc as a consequence of ligand administration (Fig.
4). With control LPS fractions prepared from non-injected
rats and subjected to this procedure without warming (4‡C/
ATP panel), only a small amount of the 55-kDa Shc isoform
migrated within the density range for endosomal markers
(density 1.075^1.105 g/ml), the vast majority of the three
Shc isoforms being recovered at a position corresponding to
the soluble cytosolic pool (density6 1.070 g/ml). The density
distribution of Shc was unchanged if control LPS fractions
were incubated at 37‡C for 30 min with an energy source
(30 min 37‡C/ATP panel). In response to EGF stimulation
(EGF 4‡C/ATP panel), a partial recruitment of the 55-kDa
protein Shc and also, but to a lesser degree, the 44-kDa pro-
tein Shc, was mainly found in the light endosomal vesicles
(density 1.075^1.105 g/ml). In contrast, when the LPS frac-
tions prepared from EGF-injected rats were warmed to 37‡C
for 15 min (EGF 15 min 37‡C/ATP panel) or 30 min (EGF 30
min 37‡C/ATP panel), a marked increase in both the 55- and
44-kDa Shc isoforms was detected in the light endosomal
Fig. 1. Density distribution of marker enzymes associated with the LPS fraction on Nycodenz gradients. The LPS fraction was isolated from
control rats and immediately subfractionated on linear Nycodenz density gradients (panels A and C), or incubated with ATP and an ATP-re-
generating system at 37‡C for 30 min (panel B). Panels A and B, galactosyltransferase (circles), acid phosphatase (squares) and 5P-nucleotidase
(triangles) activities were determined and results expressed as a percentage of total enzymatic activity recovered. Panel C, the content of proca-
thepsin B (pCB) and cathepsin D (CD) was evaluated by immunoblotting with polyclonal antibodies. Thirty Wl of each subfraction were loaded
onto each lane. Bands were visualized by immunostaining with HRP-conjugated secondary antibody.
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(15 min) and dense lysosomal (30 min) fractions (densities
1.075^1.105 g/ml and 1.11^1.14 g/ml, respectively). We were
unable to detect any association of the 66-kDa Shc protein
with either low (endosomal) or high (lysosomal) density frac-
tions. The endo-lysosomal transfer of the 55- and 44-kDa Shc
isoforms was not observed with the cell-free system incubated
without ATP and an ATP-regenerating system (EGF 30 min
37‡C panel).
4. Discussion
These biochemical studies have enabled the testing of three
hypotheses concerning EGFR sorting in hepatic endosomes:
(a) the EGFR undergoes endosome-lysosome transfer in vitro
along with EGF with comparable kinetics; (b) the internalized
EGFR accesses lysosomes under a dephosphorylated state;
and (c) a co-transfer of the 55- and 44-kDa Shc isoforms
Fig. 2. Time course of transfer of [125I]EGF and EGFR from the endosomal to the lysosomal position on Nycodenz gradients. LPS fractions
were isolated 10 min after [125I]EGF administration (107 cpm; panels A and B) or native EGF administration (5 Wg/100 g body weight; panel
C). Panels A and B, LPS fractions were incubated with ATP and an ATP-regenerating system at 4‡C for 30 min (circles), or 37‡C for 15 min
(squares), or 37‡C for 30 min (triangles), and in the absence of ATP at 37‡C for 30 min (dotted line; panel A). In panel A, results are ex-
pressed as percentages of the total radiolabel on the gradient. In panel B, the amount of degraded [125I]EGF was determined by precipitation
with trichloroacetic acid. In panel C, the EGFR content was evaluated in each subfraction by immunoblotting with polyclonal antibody. The
arrows on the right indicate the mobility of the EGFR (W170 kDa). Twenty Wl of each subfraction were loaded onto each lane. Bands were vi-
sualized by immunostaining with HRP-conjugated secondary antibody.
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occurs during the fusion process. To the best of our knowl-
edge, this is the ¢rst such a test of these hypotheses with an in
vitro fusion system.
Using the in situ liver model system for endosome-lysosome
fusion, we clearly show a transfer of EGFR through and an
association of Shc with the endo-lysosomal pathway in re-
sponse to EGF. The endo-lysosomal transfer of the internal-
ized EGFR and the adaptor protein Shc was (i) ligand-de-
pendent (it was only observed with the LPS fractions
prepared from EGF-treated rats); (ii) temperature-dependent
(it required a 37‡C incubation); and (iii) energy-dependent (it
required ATP and an ATP-regenerating system). Moreover, it
was not due to non-speci¢c aggregation of organelles during
incubation of LPS supernatants since no major change in the
density distribution of marker enzymes was observed during
the fusion process. Finally, the time course of the process is
consistent with the time taken for EGF to appear in lyso-
somes in whole liver [4] and in Hep-2 cells [22]. The similar
kinetics of lysosomal appearance of the internalized EGFR
and the EGFR-associated signaling molecule Shc suggested
an extended signal transduction consequent to ligand-medi-
ated EGFR translocation to the lysosomal apparatus [8].
Using cell-free experiments originally developed for asialo-
fetuin, a ligand of the asialoglycoprotein receptor [23], an in
vitro model for the transfer of endocytosed EGF-EGFR com-
plexes to lysosomes is proposed. As with asialofetuin, GalB-
SA, glucagon and insulin [11,23,24], the cell-free transfer of
EGF-EGFR complexes occurred from endosomes isolated at
a late stage of endocytosis (time of killing 10 min; [7,20]) and
required the addition of cytosol and an ATP-regenerating
system [11,23]. The endosome-lysosome transfer was accom-
panied by increased low molecular weight degradation prod-
ucts of EGF at the upper part of the gradient. With respect to
internalized EGFR, no immunoreactive intermediate break-
down products were detected in our study within both endo-
some and lysosome compartments (results not shown). These
data suggest that, as previously reported using the in situ liver
model [5,21], internalized EGFR is rapidly degraded by a
proteolytic process that destroys the epitopes recognized by
anti-EGFR antibodies.
Although an endosome-lysosome transfer of these ligands
was clearly established with the liver cell-free system, the en-
dosomal sorting of these polypeptides di¡ers in several re-
spects : (a) EGF (this study) and asialofetuin [23] transfer
was maximal at 30 min, as compared to 10 min for insulin
and glucagon [11]; (b) lysosomal recovery after a 10 min in-
cubation at 37‡C was low in the presence of insulin (6 12%),
moderate with EGF and glucagon (15^20%) and high with
GalBSA and asialofetuin (20^25%) [11,23]; and (c) the relative
amount of receptor recovered at the lysosomal position during
endosome-lysosome interaction was high with EGF (this
study) and very low with insulin [11].
Membrane proteins destined for the lysosome display some
form of tra⁄cking signal [25]. Sequences containing proposed
lysosomal targeting information and independent of the tyro-
sine kinase have been identi¢ed in the cytoplasmic domain of
the EGFR between residues 945^958 and 1022^1063 [26,27].
Other studies suggested that the tyrosine kinase itself plays a
Fig. 3. Tyrosine-phosphorylation state of EGFR and Shc during the in vitro endosome-lysosome transfer. LPS fractions were isolated 10 min
after EGF administration (5 Wg/100 g body weight), incubated with ATP and a regenerating system for 10 min at 4‡C (panel A) or 37‡C (panel
B) and subfractionated on linear Nycodenz density gradients. Each subfraction (150 Wl) was evaluated by Western-blotting for their immuno-
reactivity with HRP-conjugated monoclonal antibody against phosphotyrosine. The arrows on the right indicate the mobility of the EGFR
(W170 kDa) and the 55-kDa isoform of Shc. Control experiments have shown that the polyclonal anti-Shc antibody immunoprecipitated the
55-kDa endosomal tyrosine-phosphorylated protein detected in the anti-phosphotyrosine immunoblot (results not shown).
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role in generating a lysosome targeting signal [27,28]. In ac-
cordance with this hypothesis, a greater and prolonged EGFR
tyrosine phosphorylation has been demonstrated in rat liver
endosomal membranes compared to the EGFR located at the
plasma membrane [5,7,29,30]. The high phosphorylation con-
tent of internalized EGFR has been ascribed to a low disso-
ciation and degradation state of EGF within the endosome
[4,5,31]. However, shortly after, endosomal dephosphoryla-
tion induced by closely associated phosphotyrosine phospha-
tase(s) then leads to the deactivation of the EGFR’s exoge-
nous kinase activity [32]. Our results showing that the half-
time for EGFR dephosphorylation within endosomes (6 5
min) was shorter than that for lysosomal transfer of endo-
somal EGF-EGFR complexes (s 15 min) suggest that the
receptor tyrosine kinase activity appeared to have only a small
e¡ect (if any) on the sorting pattern with our in vitro endo-
lysosome fusion system. However, the rapid loss of EGFR
phosphotyrosine content occurring in endosomes observed
in the present study is compatible with a previous observation
of EGFR dephosphorylation observed using cell-free endo-
somes [32] and the in situ liver model [5,7]. Moreover, the
data that receptor mutants lacking an ATP-binding site or
an entire kinase domain are degraded as fast as wild-type
receptors have also questioned the direct involvement of ty-
rosine kinase activity in the endosomal sorting of EGFRs
[26,33]. Finally, another study on EGF recycling at di¡erent
levels of receptor occupancy showed that the regulatory role
of receptor tyrosine kinase can be revealed at low EGF con-
centrations when the lysosome targeting apparatus is not sat-
urated [33]. Thus, it is also conceivable that following admin-
istration of a saturating dose of EGF (5 Wg/100 g body
weight; [20,29]) some function of receptor kinase activity
may be reduced.
Tyrosine phosphorylation of endosomal proteins and/or the
recruitment of proteins to the endosome may also mediate
lysosomal targeting [25]. Endosomal RTK tyrosine phospho-
rylation of annexin-1 has been proposed as the mechanism by
which the EGFR at the periphery of the endosomal mem-
Fig. 4. Time course of endosome-lysosome transfer of Shc isoforms after EGF administration. LPS fractions were isolated from control rats
(4‡C/ATP and 30 min 37‡C/ATP panels) or from rats having received an EGF injection (5 Wg/100 g body weight; EGF panels). LPS fractions
were immediately subfractionated on linear Nycodenz density gradients (4‡C/ATP panel) or were incubated without ATP at 37‡C for 30 min
(EGF 30 min 37‡C panel) or with ATP and an ATP-regenerating system at 4‡C for 30 min (EGF 4‡C/ATP panel), or 37‡C for 15 min (EGF
15 min 37‡C/ATP panel), or 37‡C for 30 min (EGF 30 min 37‡C/ATP panel). The content of Shc isoforms was evaluated in each subfraction
by immunoblotting with polyclonal antibody. Fifty Wl of each subfraction were loaded onto each lane. Bands were visualized by immunostain-
ing with HRP-conjugated secondary antibody.
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brane is sorted into the inner vesicles of multivesicular endo-
somes and then subsequently targeted for degradation in ly-
sosomes [34]. Tyrosine-phosphorylated Shc and Grb2 also
represent relevant candidates at this locus [7,10,35]. The se-
quential endosomal and lysosomal association of the 44- and
55-kDa Shc isoforms in response to EGF suggests that Shc
could be the missing molecular link between endocytic and
lysosomal vesicles. Upon EGF treatment and RTK activation,
Shc proteins, as analyzed by preparative subcellular fraction-
ation [7] or by immuno£uorescence and immunoelectron mi-
croscopy [35], were found to be associated with the cytosolic
surface of endocytic structures, such as coated pits and endo-
somes, and with the peripheral cytosol. In the present study,
we con¢rmed such an intracellular localization for the adaptor
protein, and also, we provided the ¢rst evidence for a lysoso-
mal localization of the 44- and 55-kDa Shc isoforms in re-
sponse to EGF. Consistent with our data, Okada et al. [36]
have shown that the predominant EGF-dependent Shc signal-
ing pathway occurs via both the 55- and 44-kDa Shc species.
Thus, the massive recruitment of Shc proteins to lysosomal
structures suggests a new function for the adaptor protein in
RTK signal transduction and membrane tra⁄cking.
The in£uence of endosomal proteolysis on the steady-state
distribution of cognate receptor has been previously inferred
from a comparison of insulin, TGFK and EGF receptor in-
ternalization [8,9,37]. Insulin [19,38] and TGFK [37] are sub-
ject to rapid endosomal dissociation from their receptors and
subsequent degradation whereas EGF is selectively resistant
to dissociation and is only partially degraded in the endosome
[4,5]. The di¡erences in endosomal dissociation and degrada-
tion of these ligands after internalization coincided with al-
tered receptor tra⁄cking and receptor phosphotyrosine pro-
¢les through the endosomal/lysosomal pathway [5,7,37,38].
Thus, although EGF, TGFK and insulin have similar internal-
ization kinetics, the targeting of the receptor for degradation
in lysosomes (down-regulation) was achieved more e¡ectively
by EGF [11,29,37]. However, an EGF receptor-like response
in tyrosine phosphorylation of the internalized insulin recep-
tor was observed if the ligand used was the insulin analogue
H2, a genetically engineered analogue which displays a re-
duced rate of proteolysis in endosomes as compared to au-
thentic insulin [38]. Moreover, Hansen et al. [39] observed Shc
phosphorylation in response to insulin when administered to
CHO cells overexpressing the insulin receptor, and this e¡ect
was augmented in response to the analogue H2. Studies are
underway to determine whether, in response to the insulin
analogue H2, the subsequent extension of the temporal win-
dow of insulin receptor activation in the endosome [38], as
well as enhanced Shc tyrosine phosphorylation [39], cause a
translocation of both insulin receptor and Shc to the lysoso-
mal compartment.
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